Literature DB >> 19210293

Kisspeptin/metastin: a key molecule controlling two modes of gonadotrophin-releasing hormone/luteinising hormone release in female rats.

Y Uenoyama1, H Tsukamura, K-I Maeda.   

Abstract

Kisspeptin (also known as metastin), a hypothalamic peptide, has attracted attention as a key molecule in the release of gonadotrophin-releasing hormone (GnRH) in various mammalian species, such as rodents, sheep and primates. Two populations of kisspeptin neurones in the brain may control two modes of GnRH release to time the onset of puberty and regulate oestrous cyclicity in rats and mice. One population of kisspeptin neurones, located in the anteroventral periventricular nucleus, appears to be responsible for the induction of the GnRH surge that leads to the luteinising hormone surge and ovulation. The other, located in the hypothalamic arcuate nucleus, appears to be involved in generating GnRH pulses, resulting in luteinising hormone pulses followed by follicular development and steroidogenesis in the ovary. The present review focuses on the physiological role of the two populations of kisspeptin neurones in controlling gonadal functions by generating the two modes of GnRH release in a female rat model.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19210293     DOI: 10.1111/j.1365-2826.2009.01853.x

Source DB:  PubMed          Journal:  J Neuroendocrinol        ISSN: 0953-8194            Impact factor:   3.627


  12 in total

Review 1.  Recent discoveries on the control of gonadotrophin-releasing hormone neurones in nonhuman primates.

Authors:  E Terasawa; J R Kurian; K A Guerriero; B P Kenealy; E D Hutz; K L Keen
Journal:  J Neuroendocrinol       Date:  2010-05-08       Impact factor: 3.627

2.  Leptin is not the critical signal for kisspeptin or luteinising hormone restoration during exit from negative energy balance.

Authors:  C True; M A Kirigiti; P Kievit; K L Grove; M S Smith
Journal:  J Neuroendocrinol       Date:  2011-11       Impact factor: 3.627

Review 3.  The neuroendocrine basis of lactation-induced suppression of GnRH: role of kisspeptin and leptin.

Authors:  M Susan Smith; Cadence True; K L Grove
Journal:  Brain Res       Date:  2010-08-19       Impact factor: 3.252

4.  Presence of kisspeptin-like immunoreactivity in human adrenal glands and adrenal tumors.

Authors:  Kazuhiro Takahashi; Itaru Shoji; Akiko Shibasaki; Ichiro Kato; Keisuke Hiraishi; Hajime Yamamoto; Kiriko Kaneko; Osamu Murakami; Ryo Morimoto; Fumitoshi Satoh; Sadayoshi Ito; Kazuhito Totsune
Journal:  J Mol Neurosci       Date:  2009-11-07       Impact factor: 3.444

Review 5.  Physiology of the gonadotrophin-releasing hormone (GnRH) neurone: studies from embryonic GnRH neurones.

Authors:  S Constantin
Journal:  J Neuroendocrinol       Date:  2011-06       Impact factor: 3.627

Review 6.  Kiss of the mutant mouse: how genetically altered mice advanced our understanding of kisspeptin's role in reproductive physiology.

Authors:  Heather M Dungan Lemko; Carol F Elias
Journal:  Endocrinology       Date:  2012-09-25       Impact factor: 4.736

7.  Endogenous kisspeptin tone is a critical excitatory component of spontaneous GnRH activity and the GnRH response to NPY and CART.

Authors:  Saurabh Verma; Melissa A Kirigiti; Robert P Millar; Kevin L Grove; M Susan Smith
Journal:  Neuroendocrinology       Date:  2014-07-07       Impact factor: 4.914

8.  Characterisation of arcuate nucleus kisspeptin/neurokinin B neuronal projections and regulation during lactation in the rat.

Authors:  Cadence True; Melissa Kirigiti; Philippe Ciofi; Kevin L Grove; M Susan Smith
Journal:  J Neuroendocrinol       Date:  2011-01       Impact factor: 3.627

9.  Kisspeptin receptor haplo-insufficiency causes premature ovarian failure despite preserved gonadotropin secretion.

Authors:  Francisco Gaytan; David Garcia-Galiano; Mauricio D Dorfman; Maria Manfredi-Lozano; Juan M Castellano; Gregory A Dissen; Sergio R Ojeda; Manuel Tena-Sempere
Journal:  Endocrinology       Date:  2014-06-02       Impact factor: 4.736

10.  Safety Evaluation of KP-10 (Metastin 45-54) Following once Daily Intravenous Administration for 14 Days in Dog.

Authors:  Pramod S Terse; James Peggins; Stephanie B Seminara
Journal:  Int J Toxicol       Date:  2021-06-14       Impact factor: 2.032

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.